Key points
- Underlying NPAT down 41% to $16.1m
- Revenue down 1% to $269.46m
- International segment revenue up 15%
- Net debt increased to $101.2m
- Dividend payout ratio target 60-70% of Underlying NPAT
Full summary
Monash IVF Group Ltd released its FY26 financial report showing a 41% decline in Underlying Net Profit After Tax (Underlying NPAT) to $16.1m from $27.4m in FY25. Revenue decreased by 1% to $269.46m due to softness in the Australian market, partially offset by growth in international and ancillary revenue streams. The Australian segment saw a 2% revenue decline and a 38% drop in Underlying EBIT, while the international segment experienced a 15% revenue increase and a 19% rise in Underlying EBIT. The Group's market share improved to 20.2% in the second half. Depreciation and amortization increased by $1.3m, and net finance costs rose by $1.5m due to higher borrowing levels. Net debt increased to $101.2m, and the Board approved a 3-year extension to the banking facility with an increased limit of $20m.
Guidance
FY26 Underlying NPAT $16.1m, Revenue $269.46m
Outlook
Monash IVF Group Ltd expects cost efficiency programs to gain momentum in FY27, with the Brisbane facility expected to increase revenue and capacity.